| Basics |
| Company: |
Pacira BioSciences, Inc. |
| IPO Date: |
February 3, 2011 |
| Sector: |
Healthcare |
| Industry: |
Drug Manufacturers |
| Market Cap: |
$1.16B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.88 | 2.09%
|
| Avg Daily Range (30 D): |
$0.54 | 2.22%
|
| Avg Daily Range (90 D): |
$0.42 | 2.13%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.52M |
| Avg Daily Volume (30 D): |
.68M |
| Avg Daily Volume (90 D): |
.55M |
| Trade Size |
| Avg Trade Size (Sh.): |
88 |
| Avg Trade Size (Sh.) (30 D): |
57 |
| Avg Trade Size (Sh.) (90 D): |
54 |
| Institutional Trades |
| Total Inst.Trades: |
8,499 |
| Avg Inst. Trade: |
$1.76M |
| Avg Inst. Trade (30 D): |
$1.72M |
| Avg Inst. Trade (90 D): |
$1.9M |
| Avg Inst. Trade Volume: |
.04M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.28M |
| Avg Closing Trade (30 D): |
$2.79M |
| Avg Closing Trade (90 D): |
$2.77M |
| Avg Closing Volume: |
55.37K |
|
|
|
|
| News |
Feb 21, 2025 @ 7:28 PM
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Pacira B...
Source: N/A
|
Feb 20, 2025 @ 9:13 PM
PCRX Investors Have Opportunity to Lead Pacira Bio...
Source: Prnewswire
|
Feb 20, 2025 @ 3:05 AM
PACIRA BIOSCIENCES SHAREHOLDER ALERT: CLAIMSFILER ...
Source: Claimsfiler
|
Feb 19, 2025 @ 9:00 PM
PCRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman...
Source: Bronstein, Gewirtz & Grossman, Llc
|
Feb 18, 2025 @ 11:27 PM
PACIRA BIOSCIENCES SHAREHOLDER ALERT BY FORMER LOU...
Source: Kahn Swick & Foti, Llc
|
| Financials |
| |
TTM |
Q3 2024 |
Q2 2024 |
|
Basic EPS
|
$-1.97
|
$-3.11
|
$.41
|
|
Diluted EPS
|
$-1.98
|
$-3.11
|
$.39
|
|
Revenue
|
$ 694.96M
|
$ 168.57M
|
$ 178.02M
|
|
Gross Profit
|
$ 516.72M
|
$ 129.71M
|
$ 133.76M
|
|
Net Income / Loss
|
$ -90.73M
|
$ -143.47M
|
$ 18.89M
|
|
Operating Income / Loss
|
$ -64.91M
|
$ -139.53M
|
$ 28.24M
|
|
Cost of Revenue
|
$ 178.23M
|
$ 38.86M
|
$ 44.26M
|
|
Net Cash Flow
|
$ 146.85M
|
$ -1.09M
|
$ 63M
|
|
PE Ratio
|
|
|
|
|
